全文获取类型
收费全文 | 18763篇 |
免费 | 2533篇 |
国内免费 | 9篇 |
出版年
2021年 | 229篇 |
2019年 | 185篇 |
2018年 | 215篇 |
2017年 | 174篇 |
2016年 | 313篇 |
2015年 | 484篇 |
2014年 | 593篇 |
2013年 | 810篇 |
2012年 | 918篇 |
2011年 | 876篇 |
2010年 | 549篇 |
2009年 | 539篇 |
2008年 | 735篇 |
2007年 | 725篇 |
2006年 | 685篇 |
2005年 | 615篇 |
2004年 | 643篇 |
2003年 | 628篇 |
2002年 | 596篇 |
2001年 | 591篇 |
2000年 | 567篇 |
1999年 | 490篇 |
1998年 | 271篇 |
1997年 | 251篇 |
1996年 | 235篇 |
1995年 | 242篇 |
1994年 | 235篇 |
1993年 | 210篇 |
1992年 | 416篇 |
1991年 | 376篇 |
1990年 | 399篇 |
1989年 | 344篇 |
1988年 | 338篇 |
1987年 | 332篇 |
1986年 | 325篇 |
1985年 | 341篇 |
1984年 | 265篇 |
1983年 | 246篇 |
1982年 | 211篇 |
1981年 | 214篇 |
1980年 | 180篇 |
1979年 | 290篇 |
1978年 | 231篇 |
1977年 | 190篇 |
1976年 | 184篇 |
1975年 | 185篇 |
1974年 | 199篇 |
1973年 | 183篇 |
1972年 | 201篇 |
1969年 | 171篇 |
排序方式: 共有10000条查询结果,搜索用时 125 毫秒
51.
W. T. Brown 《American journal of human genetics》1996,58(5):903
52.
Karen L. Lindsay Christian Hellmuth Olaf Uhl Claudia Buss Pathik D. Wadhwa Berthold Koletzko Sonja Entringer 《PloS one》2015,10(12)
Pregnancy is characterized by a complexity of metabolic processes that may impact fetal development and ultimately, infant health outcomes. However, our understanding of whole body maternal and fetal metabolism during this critical life stage remains incomplete. The objective of this study is to utilize metabolomics to profile longitudinal patterns of fasting maternal metabolites among a cohort of non-diabetic, healthy pregnant women in order to advance our understanding of changes in protein and lipid concentrations across gestation, the biochemical pathways by which they are metabolized and to describe variation in maternal metabolites between ethnic groups. Among 160 pregnant women, amino acids, tricarboxylic acid (TCA) cycle intermediates, keto-bodies and non-esterified fatty acids were detected by liquid chromatography coupled with mass spectrometry, while polar lipids were detected through flow-injected mass spectrometry. The maternal plasma concentration of several essential and non-essential amino acids, long-chain polyunsaturated fatty acids, free carnitine, acetylcarnitine, phosphatidylcholines and sphingomyelins significantly decreased across pregnancy. Concentrations of several TCA intermediates increase as pregnancy progresses, as well as the keto-body β-hydroxybutyrate. Ratios of specific acylcarnitines used as indicators of metabolic pathways suggest a decreased beta-oxidation rate and increased carnitine palmitoyltransferase-1 enzyme activity with advancing gestation. Decreasing amino acid concentrations likely reflects placental uptake and tissue biosynthesis. The absence of any increase in plasma non-esterified fatty acids is unexpected in the catabolic phase of later pregnancy and may reflect enhanced placental fatty acid uptake and utilization for fetal tissue growth. While it appears that energy production through the TCA cycle increases as pregnancy progresses, decreasing patterns of free carnitine and acetylcarnitine as well as increased carnitine palmitoyltransferase-1 rate and β-hydroxybutyrate levels suggest a concomitant upregulation of ketogenesis to ensure sufficient energy supply in the fasting state. Several differences in metabolomic profiles between Hispanic and non-Hispanic women demonstrate phenotypic variations in prenatal metabolism which should be considered in future studies. 相似文献
53.
A Macintosh Hypertalk program (Hypercard stack)for use in phylogenetic comparative analysis of RNA structureis described. The program identifies covariations and compensatorychanges in RNA sequence alignments, for use in the constructionof secondary structure models or the identification of tertiaryinteractions. The results of an analysis are presented eitheras a list of positions in the alignment which covary, or asa 2-dimensional matrix in which potential helices in the secondarystructure appear as diagonal patterns.
Received on January 7, 1991; accepted on March 19, 1991 相似文献
54.
55.
Christine E. Brown Charles D. Warden Renate Starr Xutao Deng Behnam Badie Yate-Ching Yuan Stephen J. Forman Michael E. Barish 《PloS one》2013,8(10)
A major challenge for successful immunotherapy against glioma is the identification and characterization of validated targets. We have taken a bioinformatics approach towards understanding the biological context of IL-13 receptor α2 (IL13Rα2) expression in brain tumors, and its functional significance for patient survival. Querying multiple gene expression databases, we show that IL13Rα2 expression increases with glioma malignancy grade, and expression for high-grade tumors is bimodal, with approximately 58% of WHO grade IV gliomas over-expressing this receptor. By several measures, IL13Rα2 expression in patient samples and low-passage primary glioma lines most consistently correlates with the expression of signature genes defining mesenchymal subclass tumors and negatively correlates with proneural signature genes as defined by two studies. Positive associations were also noted with proliferative signature genes, whereas no consistent associations were found with either classical or neural signature genes. Probing the potential functional consequences of this mesenchymal association through IPA analysis suggests that IL13Rα2 expression is associated with activation of proinflammatory and immune pathways characteristic of mesenchymal subclass tumors. In addition, survival analyses indicate that IL13Rα2 over-expression is associated with poor patient prognosis, a single gene correlation ranking IL13Rα2 in the top ~1% of total gene expression probes with regard to survival association with WHO IV gliomas. This study better defines the functional consequences of IL13Rα2 expression by demonstrating association with mesenchymal signature gene expression and poor patient prognosis. It thus highlights the utility of IL13Rα2 as a therapeutic target, and helps define patient populations most likely to respond to immunotherapy in present and future clinical trials. 相似文献
56.
Regulatory and essential light-chain-binding sites in myosin heavy chain subfragment-1 mapped by site-directed mutagenesis 总被引:2,自引:0,他引:2
E J Mitchell J Karn D M Brown A Newman R Jakes J Kendrick-Jones 《Journal of molecular biology》1989,208(1):199-205
Site-directed mutagenesis of the cloned subfragment-1 (S-1) region of the unc-54 gene, encoding the myosin heavy chain B (MHC B) from Caenorhabditis elegans, has been used to locate binding sites for the regulatory and essential light chains. MHC B S-1 synthesized in Escherichia coli co-migrated with rabbit skeletal muscle myosin S-1 (Mr 90,000), was recognized by anti-nematode myosin antiserum on immunoblots, and specifically bound to 125I-labelled regulatory and essential light chains in a gel overlay assay. Deletion of 102 residues from the C terminus (mutant 655) reduced regulatory and essential light-chain binding to about 30% and 20% of wild-type levels, respectively. Similar reductions in relative binding of the two light chains were seen with mutant 534, in which 38 residues were deleted from the C terminus. Potential binding sites within 75 residues of the C terminus of S-1 were mapped by construction of five other mutant S-1 clones (398, 399, 400, 409 and 411) containing internal deletions of ten to 12 amino acid residues. These showed up to 30% reductions in their ability to bind essential light chains, but did not differ significantly from wild-type in their ability to bind regulatory light chains. Another mutant, 415, containing a deletion of a conserved acidic hexapeptide, E-D-I-R-D-E, showed enhancement of binding of regulatory and essential light chains to 150% and 165% of wild-type levels. Hence, the major binding sites for both light chains are within 38 amino acid residues of the C terminus. 相似文献
57.
58.
59.
60.